Glucocorticoids suppress bone formation via the osteoclast.

Cited by (384)

Items 101–200 of 384

1. The Crossroads between Infection and Bone Loss
   Tiago Carvalho Oliveira, Maria Salomé Gomes, Ana Cordeiro Gomes · 2020 · Microorganisms
2. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity
   H. Herschel Conaway, Petra Henning, Anita Lie, Jan Peter Tuckermann, Ulf H. Lerner · 2016 · Bone
3. Should bisphosphonates be used for long‐term treatment of glucocorticoid‐induced osteoporosis?
   Steven L. Teitelbaum, Margaret Seton, Kenneth G. Saag · 2010 · Arthritis & Rheumatism
4. Inhibition of glycogen synthase kinase-3β attenuates glucocorticoid-induced bone loss
   Feng‐Sheng Wang, Jih‐Yang Ko, Lin‐Hsiu Weng, Da‐Wei Yeh, Huei-Jing Ke, Shin-Long Wu · 2009 · Life Sciences
5. Inhaled Corticosteroids and Bone Health
   Carolyn Chee, Luckni Sellahewa, Joseph M Pappachan · 2015 · The Open Respiratory Medicine Journal
6. Glucocorticoid-induced osteoporosis
   Karen A. Koenig Berris, Anita Lopes Repp, Michael Kleerekoper · 2007 · Current Opinion in Endocrinology Diabetes and Obesity
7. Experimental assessment of nutrition and bone growth's velocity effects on Harris lines formation
   Marta P. Alfonso‐Durruty · 2011 · American Journal of Physical Anthropology
8. New understanding of glucocorticoid action in bone cells
   H. J. Kim · 2010 · BMB Reports
9. Animal models to explore the effects of glucocorticoids on skeletal growth and structure
   Claire Louise Wood, Ondřej Souček, Sze Choong Wong, Farasat Zaman, Colin Farquharson, Lars S Savendahl, S. Faisal Ahmed · 2017 · Journal of Endocrinology
10. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions
    Irene E. M. Bultink, Marijke Baden, Willem Frederik Lems · 2013 · Expert Opinion on Pharmacotherapy
11. Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone
    M. Piemontese, Melda Onal, Jinhu Xiong, Yiying Wang, Maria Almeida, Jeff D. Thostenson, Robert S. Weinstein, Stavros C. Manolagas, Charles A. O’Brien · 2015 · Bone
12. Glucocorticoid-induced delayed fracture healing and impaired bone biomechanical properties in mice
    Yanzhi Liu, Mohammed P. Akhter, Xiang Gao, Xiao-yan Wang, Xiao-bei Wang, Gang Zhao, Xin Wei, Hao-Jun Wu, Hang Chen, Dong Wang et al. · 2018 · Clinical Interventions in Aging
13. The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo
    H. J. Kim, Kaihua Zhang, Lihong Zhang, Frederick Patrick Ross, Steven L. Teitelbaum, Roberta Faccio · 2009 · Proceedings of the National Academy of Sciences
14. Mineral and Bone Disorders After Kidney Transplantation
    Chandan Vangala, Jenny Szu-Chin Pan, Ronald Timothy Cotton, Venkat Ramanathan · 2018 · Frontiers in Medicine
15. Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies
    Mikkel Bo Brent · 2023 · Pharmacology & Therapeutics
16. Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation
    Jung Min Hong, Steven L. Teitelbaum, Taeho Kim, Frederick Patrick Ross, Shin‐Yoon Kim, Hyun‐Ju Kim · 2010 · Journal of Bone and Mineral Research
17. NIK Stabilization in Osteoclasts Results in Osteoporosis and Enhanced Inflammatory Osteolysis
    Chang Yang, Kathleen McCoy, Jennifer L. Davis, Marc Schmidt‐Supprian, Yoshiteru Sasaki, Roberta Faccio, Deborah V. Novack · 2010 · PLoS ONE
18. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy
    Chloe G. Fenton, Craig L. Doig, Syeda Fareed, Amy J. Naylor, Alexander P. Morrell, Owen Addison, Corinna Wehmeyer, Christopher Dominic Buckley, Mark Stuart Cooper, Gareth Geoffrey Lavery et al. · 2019 · Arthritis Research & Therapy
19. Advances in experimental models of osteonecrosis of the femoral head
    Zilin Li, Wenkai Shao, Xiao Lv, Bo Wang, Lizhi Han, Song Gong, Ping Wang, Yong Feng · 2023 · Journal of Orthopaedic Translation
20. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions
    Michelle Kinder, Allison R. Greenplate, William R. Strohl, Robert E. Jordan, Randall J. Brezski · 2015 · mAbs
21. Clinical and Basic Aspects of Glucocorticoid Action in Bone
    Barbara E. Kream, Leland Graves, Barbara P. Lukert · 2008 · Elsevier eBooks
22. BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism
    Ágnes Szappanos, Attila Patócs, Judit Tõke, Belema Boyle, Márta Sereg, Judit Majnik, Gábor Borgulya, Ibolya Varga, István Likó, Kàroly Rácz et al. · 2009 · Clinical Endocrinology
23. Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature
    Gaetano Caramori, Paolo Ruggeri, Fabio Arpinelli, Laura Salvi, Giuseppe Girbino · 2019 · International Journal of COPD
24. cAMP/PKA Signaling Inhibits Osteogenic Differentiation and Bone Formation in Rodent Models
    Ramakrishnaiah Siddappa, Winfried R. Mulder, Ilse Steeghs, Christine van de Klundert, Hugo Fernandes, Jun Liu, Roel J. Arends, Clemens van Blitterswijk, Jan de Boer · 2009 · Tissue Engineering Part A
25. Osteoprotegerin Prevents Glucocorticoid-Induced Osteocyte Apoptosis in Mice
    Robert S. Weinstein, Charles A. O’Brien, Maria Almeida, Haibo Zhao, Paula K. Roberson, Robert L. Jilka, Stavros C. Manolagas · 2011 · Endocrinology
26. Glucocorticoids Disrupt Skeletal Angiogenesis Through Transrepression of NF-κB–Mediated Preosteoclast Pdgfb Transcription in Young Mice
    Yi Peng, Shan Lv, Yusheng Li, Jianxi Zhu, Shijie Chen, Gehua Zhen, Xu Cao, Song Wu, Janet L. Crane · 2020 · Journal of Bone and Mineral Research
27. Lactobacillus plantarum attenuates glucocorticoid-induced osteoporosis by altering the composition of rat gut microbiota and serum metabolic profile
    Siying Li, Xuebing Han, Naiyuan Liu, Jiang Chang, Gang Liu, Siwang Hu · 2024 · Frontiers in Immunology
28. Inhibitors of Osteoclast Formation from Rhizomes of Cibotium barometz
    Nguyễn Xuân Cường, Châu Văn Minh, Phan Văn Kiệm, Hoàng Thanh Hương, Ninh Khắc Bản, Nguyễn Xuân Nhiệm, Nguyễn Hữu Tùng, Ji‐Won Jung, Hyun‐Ju Kim, Shin‐Yoon Kim et al. · 2009 · Journal of Natural Products
29. Donor Age and Cell Passage Affect Osteogenic Ability of Rat Bone Marrow Mesenchymal Stem Cells
    Chao Li, Guojun Wei, Qun Gu, Gang Wen, Baochang Qi, Liang Xu, Shuqin Tao · 2015 · Cell Biochemistry and Biophysics
30. Effects of glucocorticoids on growth and bone mineralization
    Teresinha Lermen Donatti, Vera Hermina Kalika Koch, Liliam Takayama, Rosa Maria Rodrigues Pereira · 2011 · Jornal de Pediatria
31. The Split Personality of NKT Cells in Malignancy, Autoimmune and Allergic Disorders
    Jeffrey J. Subleski, Qun Jiang, Jonathan M. Weiss, Robert H. Wiltrout · 2011 · Immunotherapy
32. Bone Density and Cortical Structure after Pediatric Renal Transplantation
    Anniek M. Terpstra, Heidi J. Kalkwarf, Justine Shults A, Babette S. Zemel, Rachel J. Wetzsteon, Bethany Joy Foster, C. Frederic Strife, Debbie L. Foerster, Mary Beth Leonard · 2012 · Journal of the American Society of Nephrology
33. Statins, Glucocorticoids, and Nonsteroidal Anti-Inflammatory Drugs
    Jia Fu, Jill D. Bashutski, Khalid Al‐Hezaimi, Hom‐Lay Wang · 2012 · Implant Dentistry
34. Identification of a Role for the ARHGEF3 Gene in Postmenopausal Osteoporosis
    Benjamin H. Mullin, Richard Lewis Prince, Ian M. Dick, Deborah J Hart, Tim D. Spector, Frank Dudbridge, Scott G. Wilson · 2008 · The American Journal of Human Genetics
35. A Medium-Chain Fatty Acid, Capric Acid, Inhibits RANKL-Induced Osteoclast Differentiation via the Suppression of NF-κB Signaling and Blocks Cytoskeletal Organization and Survival in Mature Osteoclasts
    Hyun‐Ju Kim, Hye‐Jin Yoon, Shin‐Yoon Kim, Young‐Ran Yoon · 2014 · Molecules and Cells
36. The molecular etiology and treatment of glucocorticoid-induced osteoporosis
    Cheng-Huan Peng, Wen-Ying Lin, Kuang‐Ting Yeh, Ing‐Ho Chen, Wen‐Tien Wu, Ming‐Der Lin · 2021 · Tzu Chi Medical Journal
37. Sites of Cre-recombinase activity in mouse lines targeting skeletal cells
    Greig Couasnay, Maria‐Bernadette Madel, Joohyun Lim, Brendan Lee, Florent Elefteriou · 2020 · Journal of Bone and Mineral Research
38. G Protein‐Coupled Receptor 120 Signaling Negatively Regulates Osteoclast Differentiation, Survival, and Function
    Hyun‐Ju Kim, Hye‐Jin Yoon, Bo Kyung Kim, Woo Youl Kang, Sook Jin Seong, Mi‐sun Lim, Shin‐Yoon Kim, Young‐Ran Yoon · 2015 · Journal of Cellular Physiology
39. Strain dependent differences in glucocorticoid-induced bone loss between C57BL/6J and CD-1 mice
    Adel Ersek, Ana Isabel Espirito Santo, Youridies Vattakuzhi, Saumya George, Andrew R. Clark, Nicole J. Horwood · 2016 · Scientific Reports
40. Interleukin‐17 alleviates erastin‐induced alveolar bone loss by suppressing ferroptosis via interaction between NRF2 and p‐STAT3
    Jiaqi Bao, Zhongxiu Wang, Yuting Yang, Xufei Yu, Wenlin Yuan, Weilian Sun, Lili Chen · 2023 · Journal Of Clinical Periodontology
41. Role of the N- and C-terminal Fragments of Parathyroid-Hormone-Related Protein as Putative Therapies to Improve Bone Regeneration Under High Glucocorticoid Treatment
    Luis F de Castro, Daniel Lozano, Sonia Dapía, Sergio Portal‐Núñez, José Ramón Caeiro, Enrique Gómez‐Barrena, Pedro Esbrit · 2009 · Tissue Engineering Part A
42. A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass
    Mónica Ibáñez, Ana M. Ortiz, Isabel Castrejón, Alberto García-Vadillo, Inmaculada Carvajal, Santos Castañeda, Isidoro González‐Álvaro · 2010 · Arthritis Research & Therapy
43. Effects of P-Glycoprotein on Steroid-Induced Osteonecrosis of the Femoral Head
    Ning Han, Zuoqin Yan, Changan Guo, Feng Shen, Jun Liu, Yuxing Shi, Zhiyong Zhang · 2010 · Calcified Tissue International
44. Mediation of nonerosive arthritis in a mouse model of lupus by interferon‐α–stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis
    Kofi A. Mensah, Alexis Mathian, Lin Ma, Lianping Xing, Christopher T. Ritchlin, Edward M. Schwarz · 2010 · Arthritis & Rheumatism
45. The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids
    Balooch, Guive, Yao, Wei, Ager, Joel W., Balooch, Mehdi, Nalla, Ravi K., Porter, Alexandra E., Ritchie, Robert O., Lane, Nancy E. · 2007 · Arthritis & Rheumatism
46. Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
    Kalina Duszka, Walter Wahli · 2018 · International Journal of Molecular Sciences
47. Autophagy and bone diseases
    Marie-Charlotte Trojani, Sabine Santucci‐Darmanin, Véronique Breuil, Georges F. Carle, Valérie Pierrefite‐Carle · 2021 · Joint Bone Spine
48. Effects of glucocorticoids on inflammation and arthritis
    Eric Francis Morand · 2007 · Current Opinion in Rheumatology
49. Label-free fluorescent detection of alkaline phosphatase with vegetable waste-derived green carbon probes
    Moon Il Kim, So‐Young Park, Ki Soo Park, Seong-Rok Kim, Jong‐Pil Kim, Young‐Chul Lee, Hyun Uk Lee, Hyun Gyu Park · 2018 · Sensors and Actuators B Chemical
50. Minireview: Nuclear Receptor Regulation of Osteoclast and Bone Remodeling
    Zixue Jin, Xiaoxiao Li, Yihong Wan · 2014 · Molecular Endocrinology
51. Systematic assessment of the human osteoblast transcriptome in resting and induced primary cells
    Elin Grundberg, Helena Brändström, Kevin C. L. Lam, Scott Gurd, Bing Ge, Eef Harmsen, Andreas Kindmark, Östen Ljunggren, Hans Mallmin, Olle Nilsson et al. · 2008 · Physiological Genomics
52. Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia
    Zahra Achiou, Hechmi Toumi, Jérôme Touvier, Arnaud Boudenot, Rustem E. Uzbekov, Michael S. Ominsky, Stéphane Pallu, Éric Lespessailles · 2015 · Bone
53. Glucocorticoid-Induced Osteoporosis: A Review
    Béatrice Bouvard, Érick Legrand, Maurice Audran, Daniel Chappard · 2009 · Clinical Reviews in Bone and Mineral Metabolism
54. Tensin 3 is a new partner of Dock5 that controls osteoclast podosome organization and activity
    Heiani Touaitahuata, Anne Morel, Serge Urbach, Julio Mateos Langerak, Sylvain de Rossi, Anne Blangy · 2016 · Journal of Cell Science
55. Autophagy-dependent mitochondrial function regulates osteoclast differentiation and maturation
    Shigeki Aoki, Kengo Shimizu, Kousei Ito · 2020 · Biochemical and Biophysical Research Communications
56. Exploring the Interface between Inflammatory and Therapeutic Glucocorticoid Induced Bone and Muscle Loss
    Justine Michelle Webster, Chloe G. Fenton, RAMON C. J. LANGEN, Rowan Hardy · 2019 · International Journal of Molecular Sciences
57. The Glucocorticoid Receptor in Osterix-Expressing Cells Regulates Bone Mass, Bone Marrow Adipose Tissue, and Systemic Metabolism in Female Mice During Aging
    Jessica L. Pierce, Anuj K. Sharma, Rachel L. Roberts, Kanglun Yu, Debra Lima Irsik, Vivek Choudhary, Jennifer Dorn, Husam Bensreti, Reginald D. Benson, Helen Kaiser et al. · 2020 · Journal of Bone and Mineral Research
58. Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency
    Auer, Matthias K., Paizoni, Luisa, Hofbauer, Lorenz C., Rauner, Martina, Chen, Yiqing, Schmidt, Heinrich, Huebner, Angela, Bidlingmaier, Martin, Reisch, Nicole · 2020 · The Journal of Steroid Biochemistry and Molecular Biology
59. A sensitive dual colorimetric and fluorescence system for assaying the activity of alkaline phosphatase that relies on pyrophosphate inhibition of the peroxidase activity of copper ions
    Ki Soo Park, Chang Yeol Lee, Hyun Gyu Park · 2014 · The Analyst
60. Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways
    Yu Jiang, Yajun Lu, Xu Jiang, Jiawei Hu, Rong Li, Yun Liu, Guoxing Zhu, Xiaoxu Rong · 2020 · Biomedicine & Pharmacotherapy
61. PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity
    Giulia Bellini, Marco Torella, Iolanda Manzo, Chiara Tortora, Livio Luongo, Francesca Punzo, Nicola Colacurci, Brúno Nobili, Sabatino Maione, Francesca Rossi · 2016 · Pharmacological Research
62. Calcitonin and Prednisolone Display Antagonistic Actions on Bone and Have Synergistic Effects in Experimental Arthritis
    Mancini, Lucia, Paul-Clark, Mark J., Rosignoli, Guglielmo, Hannon, Robert, Martin, Jo E., Macintyre, Ian, Perretti, Mauro · 2007 · The American Journal of Pathology
63. Glucocorticoid Induced Osteoblast Apoptosis by Increasing E4BP4 Expression via Up-regulation of Bim
    Fangjing Chen, Li Zhang, Yueping Ouyang, Huapeng Guan, Qi Liu, Bin Ni · 2014 · Calcified Tissue International
64. Cannabinoid receptor 1 mediates glucocorticoid‐induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis
    Jih‐Yang Ko, Re‐Wen Wu, Shu‐Jui Kuo, Ming‐Wen Chen, Da‐Wei Yeh, Huei-Ching Ke, Shin‐Long Wu, Feng‐Sheng Wang · 2011 · Arthritis & Rheumatism
65. Col3.6-HSD2 transgenic mice: A glucocorticoid loss-of-function model spanning early and late osteoblast differentiation
    Maobin Yang, Lorin B. Trettel, Douglas J. Adams, John R. Harrison, ERNESTO M. CANALIS, Barbara E. Kream · 2010 · Bone
66. The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates
    Hiroe Sato, Naoki Kondo, Y. Wada, Takeshi Nakatsue, Seitaro Iguchi, Junichi Fujisawa, Junichiro James Kazama, Takeshi Kuroda, Masahiro Nakano, Naoto Endo et al. · 2015 · Osteoporosis International
67. Real-time fluorescence assays of alkaline phosphatase and ATP sulfurylase activities based on a novel PPi fluorescent probe
    Xiaobo Wang, Zhiyang Zhang, Xiaoyan Ma, Jinghan Wen, Zhirong Geng, Zhilin Wang · 2015 · Talanta
68. 4-Phenyl butyric acid prevents glucocorticoid-induced osteoblast apoptosis by attenuating endoplasmic reticulum stress
    Jianhui Yang, Qiong Wu, Jian-guo Lv, Huiyong Nie · 2016 · Journal of Bone and Mineral Metabolism
69. The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat
    Jessica L. Pierce, Kehong Ding, Jianrui Xu, Anuj K. Sharma, Kanglun Yu, Natalia del Mazo-Arbona, Zuleika Rodríguez-Santos, Paul J. Bernard, Wendy Bollinger Bollag, Maribeth H. Johnson et al. · 2019 · Journal of Endocrinology
70. Lipocalin-2 inhibits osteoclast formation by suppressing the proliferation and differentiation of osteoclast lineage cells
    Hyun‐Ju Kim, Hye‐Jin Yoon, Kyung‐Ae Yoon, Mi‐Ri Gwon, Sook Jin Seong, Kyoungho Suk, Shin‐Yoon Kim, Young‐Ran Yoon · 2015 · Experimental Cell Research
71. High fat diet promotes achievement of peak bone mass in young rats
    Parmanand Malvi, Vikrant Piprode, Balkrishna Chaube, Satish T. Pote, Monika Mittal, Naibedya Chattopadhyay, Mohan R. Wani, Manoj Kumar Bhat · 2014 · Biochemical and Biophysical Research Communications
72. Developmentally regulated inhibition of cell cycle progression by glucocorticoids through repression of cyclin a transcription in primary osteoblast cultures
    Yankel Gabet, Tommy Noh, Christopher Lee, Baruch Frenkel · 2010 · Journal of Cellular Physiology
73. Medication-induced osteoporosis
    Meng-Yi Weng, Nancy E. Lane · 2007 · Current Osteoporosis Reports
74. Glucocorticoids and the risk of osteoporosis
    Liron Caplan, Kenneth G. Saag · 2008 · Expert Opinion on Drug Safety
75. Poncirin prevents bone loss in glucocorticoid-induced osteoporosis in vivo and in vitro
    Hyung‐Young Yoon, Ye‐Yeon Won, Yoon‐Sok Chung · 2012 · Journal of Bone and Mineral Metabolism
76. Cortical bone quality affectations and their strength impact analysis using holographic interferometry
    Cesar G. Tavera Ruiz, Manuel H. De La Torre-Ibarra, Mauricio Flores‐Moreno, Claudio Frausto‐Reyes, Fernando Mendoza Santoyo · 2018 · Biomedical Optics Express
77. Molecular determinants of glucocorticoid actions in inflammatory joint diseases
    Ulrike Baschant, Stephan Culemann, Jan Peter Tuckermann · 2013 · Molecular and Cellular Endocrinology
78. Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages.
    Shereen M. Samir, H A Malek · 2014 · PubMed
79. Opposing effects of glucocorticoids and Wnt signaling on Krox20 and mineral deposition in osteoblast cultures
    Nathalie Leclerc, Tommy Noh, Jon P. Cogan, Dilan B. Samarawickrama, Elisheva Smith, Baruch Frenkel · 2007 · Journal of Cellular Biochemistry
80. Effects of glucocorticoids on growth and bone mineralization
    Teresinha Lermen Donatti, Vera Hermina Kalika Koch, Liliam Takayama, Rosa Maria Rodrigues Pereira · 2011 · Jornal de Pediatria
81. The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis
    Leiming Zhang, Xiaoli Li, Tianhao Ying, Tian Wang, Fenghua Fu · 2021 · Frontiers in Endocrinology
82. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy
    Kathrin Koetz, Elisabeth F. C. van Rossum, Manfred Ventz, Sven Diederich, Marcus O. Quinkler · 2012 · Clinical Endocrinology
83. Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells
    Hyun‐Ju Kim, Julia T. Warren, Shin‐Yoon Kim, Jean C. Chappel, Carl J. DeSelm, Frederick Patrick Ross, Wei Zou, Steven L. Teitelbaum · 2010 · Journal of Cellular Biochemistry
84. Glucocorticoid-induced gene tripartite motif-containing 63 (TRIM63) promotes differentiation of osteoblastic cells
    Kotaro Azuma, Tomohiko Urano, Yasuyoshi Ouchi, Satoshi Inoue · 2010 · Endocrine Journal
85. Heat shock protein 60 protects skeletal tissue against glucocorticoid-induced bone mass loss by regulating osteoblast survival
    Feng‐Sheng Wang, Re‐Wen Wu, Jih‐Yang Ko, Ming‐Hong Tai, Huei-Ching Ke, Da‐Wei Yeh, Shin-Long Wu, Ming-Wen Chen · 2011 · Bone
86. The F-actin modulator SWAP-70 controls podosome patterning in osteoclasts
    Anne Roscher, Tomoka Hasegawa, Sebastian Dohnke, Carlos Ocaña‐Morgner, Norio Amizuka, Rolf Jessberger, Annette I. Garbe · 2016 · Bone Reports
87. Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
    Sylvia Thiele, Anke Hannemann, Maria Winzer, Ulrike Baschant, Heike Weidner, Matthias A. Nauck, Rajesh V. Thakker, Martin Bornhäuser, Lorenz Christian Hofbauer, Martina Rauner · 2019 · Endocrine Connections
88. Regulation of bone metabolism by nuclear receptors
    Yuuki Imai, Shino Kondoh, Alexander Kouzmenko, Shigeaki Kato · 2008 · Molecular and Cellular Endocrinology
89. Bone Development and Remodeling
    Christa Maes, Henry M. Kronenberg · 2015 · Elsevier eBooks
90. Dental implants in patients with Sjögren's syndrome: a case series and a systematic review.
    B. Chrcanovic, J. Kisch, A. Wennerberg · 2019 · International Journal of Oral & Maxillofacial Surgery
91. When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
    Kaleen N. Hayes, Ulrike Baschant, Barbara Hauser, Andrea Michelle Burden, Elizabeth Martha Winter · 2021 · Frontiers in Endocrinology
92. Short-term glucocorticoid treatment causes spinal osteoporosis in ovariectomized rats
    Wolfgang Böcker, Thaqif El Khassawna, Natali Bettina Bauer, Katharina Brodsky, David Weisweiler, Parameswari Govindarajan, Gudrun Schlewitz, Marian Kampschulte, Lutz Dürselen, Ulrich Thormann et al. · 2014 · European Spine Journal
93. Effects of anti-osteoporosis drugs against dexamethasone-induced osteoporosis-like phenotype using a zebrafish scale-regeneration model
    Yuichi Saito, Shinsuke Nakamura, Naoki Chinen, Masamitsu Shimazawa, Hideaki Hara · 2020 · Journal of Pharmacological Sciences
94. Distinct Glucocorticoid Receptor Actions in Bone Homeostasis and Bone Diseases
    Sooyeon Lee, Benjamin Thilo Krüger, Anita A. Ignatius, Jan Peter Tuckermann · 2022 · Frontiers in Endocrinology
95. Carbon monoxide protects against ovariectomy-induced bone loss by inhibiting osteoclastogenesis
    Tien Van Phan, Ok‐Joo Sul, Ke Ke, Mi‐Hyun Lee, Woon-Ki Kim, Yeon-Soo Cho, Hyun‐Ju Kim, Shin‐Yoon Kim, Hun‐Taeg Chung, Hye‐Seon Choi · 2013 · Biochemical Pharmacology
96. Post‐genomics of bone metabolic dysfunctions and neoplasias
    Giulia Bernardini, Daniela Braconi, Adriano Spreafico, Annalisa Santucci · 2012 · PROTEOMICS
97. Nuclear Receptors in Skeletal Homeostasis
    Hao Zuo, Yihong Wan · 2017 · Current topics in developmental biology/Current Topics in Developmental Biology
98. A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology
    Mubashir Ahmad, Yasmine Hachemi, Kevin Paxian, Florian Mengele, Mascha Koenen, Jan Peter Tuckermann · 2019 · Frontiers in Immunology
99. Perioperative glucocorticosteroid treatment delays early healing of a mandible wound by inhibiting osteogenic differentiation
    Jun Li, Xianwei Wang, Chen Zhou, Laikui Liu, Yunong Wu, Dongmiao Wang, Hongbing Jiang · 2012 · Injury
100. Second generation sequencing of microRNA in Human Bone Cells treated with Parathyroid Hormone or Dexamethasone
     Navya Laxman, Carl‐Johan Rubin, Hans Mallmin, Olle Nilsson, Christian Tellgren‐Roth, Andreas Kindmark · 2015 · Bone